Placebo | ATP | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Before* | SEM† | After | SEM | % Change | Before | SEM | After | SEM | % Change | p Value‡ | |
WBC, x109/l | 5.93 | 0.38 | 5.98 | 0.34 | 0.8 | 6.08 | 0.24 | 6.07 | 0.22 | −0.1 | 0.67 |
RBC, x1012/l | 5.16 | 0.10 | 5.19 | 0.09 | 0.7 | 5.13 | 0.04 | 5.07 | 0.05 | −1.1 | 0.30 |
Hemoglobin, g/l | 156 | 2.8 | 155 | 2.4 | −1.0 | 157 | 2.2 | 156 | 2.0 | −0.8 | 0.97 |
Hematocrit, l/l | 0.46 | 0.01 | 0.46 | 0.01 | 0.0 | 0.47 | 0.01 | 0.46 | 0.01 | −1.8 | 0.54 |
MCV, μm3 | 89.7 | 0.8 | 89.3 | 1.0 | −0.5 | 90.6 | 0.8 | 89.7 | 0.8 | −1.0 | 0.94 |
MCH, pg/cell | 30.5 | 0.40 | 30.2 | 0.33 | −1.1 | 30.4 | 0.32 | 30.5 | 0.44 | 0.3 | 0.42 |
MCHC, g/l | 339 | 3.1 | 336 | 2.5 | −0.9 | 334 | 3.9 | 340 | 4.4 | 2.1 | 0.16 |
RDW,% | 13.4 | 0.1 | 13.4 | 0.1 | 0.0 | 13.1 | 0.1 | 13.2 | 0.1 | 0.8 | 0.62 |
Platelets, x109/l | 247 | 9.0 | 236 | 9.1 | −4.2 | 248 | 9.5 | 217 | 5.1 | −12.5 | 0.64 |
Neutrophils,% | 46.5 | 3.1 | 47.4 | 2.5 | 1.9 | 47.6 | 3.0 | 47.8 | 2.0 | 0.5 | 0.80 |
Lymphocytes,% | 39.6 | 3.2 | 38.4 | 2.6 | −3.0 | 39.0 | 2.8 | 38.8 | 1.7 | −0.6 | 0.74 |
Monocytes,% | 10.3 | 0.6 | 9.4 | 0.7 | −8.7 | 9.3 | 0.5 | 9.6 | 0.6 | 3.0 | 0.57 |
Eosinophils,% | 3.6 | 0.5 | 3.6 | 0.5 | 0.0 | 3.4 | 0.4 | 3.4 | 0.4 | 0.0 | 0.98 |
Basophils,% | 0.6 | 0.2 | 0.7 | 0.2 | 16.7 | 0.4 | 0.2 | 0.4 | 0.2 | −0.3 | 0.83 |
Neutrophils, x109/l | 3.2 | 0.6 | 3.3 | 0.5 | 2.5 | 3.0 | 0.3 | 2.9 | 0.2 | −2.3 | 0.27 |
Lymphocytes, x109/l | 2.4 | 0.2 | 2.5 | 0.3 | 4.1 | 2.4 | 0.2 | 2.4 | 0.1 | 2.9 | 0.99 |
Monocytes, x109/l | 0.67 | 0.08 | 0.62 | 0.08 | −7.5 | 0.82 | 0.20 | 0.61 | 0.05 | −25.6 | 0.62 |
Eosinophils, x109/l | 0.21 | 0.02 | 0.21 | 0.02 | 0.0 | 0.21 | 0.03 | 0.22 | 0.03 | 4.4 | 0.32 |
Basophils, x109/l | 0.02 | 0.01 | 0.01 | 0.01 | −50.0 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 | 0.41 |